Docetaxel Polymeric Micelles for Injection (Shandong Hubble Kisen Biological)

注射用多西他赛聚合物胶束 (山东华铂凯盛生物)

Report date: 2025/08/19 14:20:22

Base Information

Drug NameDocetaxel Polymeric Micelles for Injection (Shandong Hubble Kisen Biological)
Drug Alias Name多西他赛聚合物胶束（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin depolymerization inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumoursBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong Hubble Kisen Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Hubble Kisen Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A